DeviceTalks Podcast Network

DeviceTalks Podcast Network

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry. Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges. Our Lineup of Shows Includes: • DeviceTalks Weekly • AbbottTalks • Boston Scientific Talks • DeviceTalks AI • IntuitiveTalks • MedtechWOMEN Talks • MedtronicTalks • Neuro Innovation Talks: J&J MedTech Neurovascular • Structural Heart Talks: Edwards Lifesciences • Ortho Innovation Talks: Enovis & Zimmer Biomet • StrykerTalks Why Subscribe? Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered. If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience. Meet Your Hosts: • Tom Salemi, Editorial Director, DeviceTalks • Kayleen Brown, Managing Editor, DeviceTalks #DeviceTalks, Where Device Makers Connect.

  1. New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup

    13 HRS AGO

    New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup

    In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight. This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee. Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:08:12) - The biggest cardiology tech stories out of ACC 2026(00:11:45) - HistoSonics kicks off study using Edison histotripsy system in BPH(00:14:20) - Boston Scientific completes Valencia Technologies acquisition(00:16:00) - Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support(00:16:27) - Abbott joins $575M funding round for wearable maker WHOOP(00:22:20) - Keynote Interview, Amaza Reitmeier, CEO, Pharaoh Neuro

    57 min
  2. Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients?

    3 DAYS AGO

    Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients?

    In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown sit down with Rebecca Wilkins, divisional vice president of R&D for Abbott’s Neuromodulation business, to discuss the technologies Abbott is advancing for chronic pain and movement disorders. Wilkins explains how Abbott’s spinal cord stimulation platforms, Proclaim™ DRG Neurostimulation System, and Infinity™ deep brain stimulation system are designed to interrupt errant nervous system signals, helping patients manage conditions ranging from chronic pain and Parkinson’s disease to, potentially, treatment-resistant depression. The conversation also highlights the features shaping Abbott’s neuromodulation portfolio, including Bluetooth-enabled connectivity, the NeuroSphere™ Virtual Clinic for remote programming, improved MRI compatibility including prone MRI access, and device options that balance small size with low recharge demands. Wilkins also shares new data presented at NANS showing significant reductions in pain-related healthcare encounters for patients using Abbott’s spinal cord stimulation and DRG therapies. This episode is brought to you by Confluent Medical Technologies. To learn more about Confluent, visit: https://confluentmedical.com/. Make sure to catch Confluent's March DeviceTalks Tuesdays webinar highlighting its new technology, Filmcast Select™: https://event.on24.com/wcc/r/5241831/7E70E13249532E05CA8FB3D51421AD71?partnerref=confluent *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Intro: Reflecting on Season 3(00:05:22) - (Part 1) Interview with Confluent Medical's Brittany Mai(00:07:56) - Keynote Interview: Rebecca Wilkins, DVP of R&D at Abbott’s neuromodulation business(00:13:57) - A Personal Connection: How DBS Impacted a Family(00:16:21) - Innovation in Connectivity: Bluetooth and NeuroSphere™ Virtual Clinic(00:21:37) - (Part 2) Interview with Confluent Medical's Brittany Mai(00:24:42) - Targeted Therapy: Understanding Spinal Cord and DRG Stimulation(00:32:37) - Breaking Barriers: MRI Compatibility and Device Longevity(00:36:04) - New Data from NANS: Validating Patient Outcomes

    45 min
  3. Why Medtronic is leaning into AI, new technology, and partnerships to expand monitoring reach

    27 MAR

    Why Medtronic is leaning into AI, new technology, and partnerships to expand monitoring reach

    In this episode of DeviceTalks Weekly, Medtronic’s Blake Tatum, Vice President of U.S. Commercial for Acute Care & Monitoring, joins Host Tom Salemi to unpack the evolving patient monitoring landscape. Tatum shares how Medtronic is integrating sensors, data, and digital health to support clinicians from the ICU to the home, why partnerships are reshaping the competitive playbook, and how lessons from the pandemic are driving a new focus on accuracy, equity, and connectivity in care delivery. This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.Devicetalks.com to check out the amazing agenda! Then Salemi and MassDevice editor Chris Newmarker review this week’s MedTech newsmakers including surgical robotics, Abbott, Stryker, Boston Scientific, and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:15) - 10 surgical robotics companies you need to know (Go to MassDevice.com to download the report)(00:08:09) - Abbott completes Exact Sciences acquisition(00:09:37) - Stryker reportedly brings most services affected by cyberattack back online(00:11:20) - Boston Scientific has reportedly had pacemaker battery problems for years(00:14:01) - Round up of Medtronic News(00:21:30) - Keynote interview with Medtronic’s Blake Tatum

    56 min
  4. Distalmotion CEO explains how Dexter fits into an evolving view on surgical robotics

    20 MAR

    Distalmotion CEO explains how Dexter fits into an evolving view on surgical robotics

    In this episode of DeviceTalks Weekly, Distalmotion CEO Greg Roche updates Host Tom Salemi on the surgical robotics company’s commercial roll out of Dexter, a robotic system designed for ambulatory surgery centers. Roche shares the lessons he’s learned after a decade in surgical robotics and why he’s particularly optimistic about his company’s outcome. You can hear Greg Roche’s first appearance on the podcast right here: https://www.devicetalks.com/why-distalmotions-roche-sees-dexters-small-size-as-big-advantage-in-the-robotics-surgical-market/  This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the registration price. Rachel Robinson, COO of MassMEDIC, joins the MassDevice Newmarker’s Newsmakers with Salemi and Editor Chris Newmarker – Stryker, CMR Surgical, Revolve Surgical, JenaValve, and MassDevice’s Surgical Robotics Special Report for 2026. You can download the report with 70+ profiles of surgical robotics companies here - https://www.massdevice.com/surgical-robotics-special-report-2026/ Robinson also welcomes listeners to attend MassMEDIC’s Symposium & Gala on April 2. Go to MassMEDIC.com to see the agenda and to register. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:15) - MassMEDIC COO Rachel Robinson discusses the Medtech Impact Symposium & Gala(00:10:05) - MassDevice’s Surgical Robotics Special Report for 2026(00:11:58) - Stryker CEO Kevin Lobo joins GE HealthCare board of directors(00:14:35) - CMR Surgical, Nvidia collab to train next-gen surgical robots(00:18:02) - Revolve Surgical wins FDA clearance for surgical robot(00:21:00) - JenaValve wins FDA nod for Trilogy heart valve system(00:25:45) - Keynote Interview – Greg Roche, CEO, Distalmotion

    57 min
  5. CEO Stephen From Is Building Tested Strategies into a New Plan to Put Vicarious Surgical Back on Track

    13 MAR

    CEO Stephen From Is Building Tested Strategies into a New Plan to Put Vicarious Surgical Back on Track

    In this episode of the DeviceTalks Weekly podcast, Stephen From, the new CEO of Vicarious Surgical, explains why he jumped the chasm from biotech to lead surgical robotics company Vicarious Surgical. From brings years of experience bringing products to market and he lays out the plan for Vicarious’s single-incision robot to Host Tom Salemi. Next, Salemi interviews Bill Frey, Regional Sales Engineer, Harmonic Drive, about the unique challenges of surgical robotics. For more information about Harmonic Drive, go to www.harmonicdrive.net. But we’ll start off with Salemi and MassDevice Editor Chris Newmarker discussing this week’s Newmarker’s Newsmakers – Petal Surgical, Abbott, Stryker, and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:50) - Chris and Tom talk turkeys(00:06:20) - Incisionless surgical robot developer Petal Surgical adds more funding, Fred Moll joins board(00:09:50) - Abbott completes $20B offering for Exact Sciences buy(00:12:02) - Stryker launches SmartHospital platform to elevate care delivery(00:15:00) - Stryker reportedly hit with Iran-backed cyberattack(00:16:41) - Medtronic makes neurovascular play with $550M Scientia Vascular buy(00:18:55) - FOMO - Bill Frey, Regional Sales Engineer, Harmonic Drive(00:30:05) - Keynote Conversation, Stephen From, CEO, Vicarious Surgical

    1hr 7min
  6. How Stryker’s Smart Hospital platform is supporting professionals on healthcare’s frontlines

    6 MAR

    How Stryker’s Smart Hospital platform is supporting professionals on healthcare’s frontlines

    In this episode of the DeviceTalks Weekly podcast, Jessica Mathieson, president of Stryker’s medical business, takes Host Tom Salemi to the frontlines of healthcare, where hospitals are seeking support for healthcare professionals. Mathieson will explain how the acquisitions of Vocera and Care AI have enabled Stryker to build a comprehensive communications and monitoring tool that can keep nurses safe while improving patient care. Find Mathieson’s first visit to DeviceTalks here: https://www.stryker.com/us/en/about/news/2022/acute-care-s-mathieson-explains-how-vocera-fits-into-stryker-s-g.html And as an added bonus, on Monday, March 9th, Stryker announced that it launched its new SmartHospital platform. Learn more here: https://www.massdevice.com/stryker-launches-smarthospital-platform-care-delivery/ In this week’s FOMO, Ignacio Pedrosa, Advanced Solutions Engineer at Novanta, talks with Kayleen Brown about the company’s work to make surgical robotic systems smaller, smarter and more capable. For more information, go to https://novanta.com. In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker and Salemi talk about their favorite flavor of Girl Scout cookie. (Buy yours in the link below) before talking about the top stories of the week – Smith & Nephew, Science Corp., Boston Scientific, Medtronic and, in a bit of Meta-ness – an article about Jenny Barba’s appearance on the podcast two weeks ago! Go here to buy cookies from Chris’s daughter! - https://digitalcookie.girlscouts.org/scout/stella590572 *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe  Chapters (00:05:42) - Smith+Nephew posts Q4 sales beat amid overall strategy shift(00:07:39) - 3 tips for first-time medtech entrepreneurs from a venture capital pro(00:09:51) - Science Corp. closes $230M Series C to support BCI tech(00:13:27) - Boston Scientific wins expanded CE mark for Farapulse in persistent AFib(00:17:01) - Medtronic, GE HealthCare expand strategic alliance

    59 min
  7. Armor Medical’s wearable could give earlier warnings of severe hemorrhaging before it’s too late

    27 FEB

    Armor Medical’s wearable could give earlier warnings of severe hemorrhaging before it’s too late

    In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make an impact, but the focus of her passion became clear after a frightening experience of her own. Today, she’s CEO of a startup building a wearable device that can serve as an early warning system for hemorrhaging. This could immediately protect the lives of women giving birth and ultimately replace guesswork with irrefutable data. Armor Medical won MedTech Innovator’s top award at AdvaMed in the fall. This episode is sponsored by DeviceTalks Minnesota. Speaking of MedTech Innovator, CEO Paul Grand joins Tom Salemi and Chris Newmarker to analyze this week’s top Newsmakers from MassDevice — DePuy Synthes, Medtronic, Pharaoh Neuro, Stryker, and Boston Scientific. Grand also introduced MedTech Innovator’s Radar Forum: https://medtechinnovator.org/radarforum2026/ *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:30) - MedTech Innovator Radar Forum(00:12:06) - Pharaoh Neuro raises $20M, names former Medtronic exec as CEO(00:15:05) - Medtronic MiniMed Diabetes unit prices IPO at up to $784M(00:20:40) - Medtronic wins CE mark for next-gen GI Genius module, ColonPRO software(00:22:50) - AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker(00:24:56) - Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit(00:34:13) - Keynote interview: Kelsey Mayo, Co-founder and CEO, Armor Medical

    1hr 31min
  8. How one venture firm is working to unlock MedTech; Where J&J/Shockwave is taking IVL next

    20 FEB

    How one venture firm is working to unlock MedTech; Where J&J/Shockwave is taking IVL next

    In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown takes the helm, leading a keynote interview with Jenny Barba, co-founder of Features Capital. Barba shares her path into venture capital, identifies winning strategies for start-ups, and highlights some of the more exciting companies in the Features Capital portfolio. A special thanks to this episode’s sponsor, SHL Healthcare, for supporting DeviceTalks! Go to www.shl-healthcare.com for more information. As a special bonus, download SHL Healthcare's complimentary white paper highlighting the outcomes of using the combination of advanced sewing, welding, and electromechanical assembly here: https://www.devicetalks.com/wp-content/uploads/2026/02/SHL-Healthcare_Whitepaper_Integrated-Approach.pdf Kayleen Brown also leads our FOMO interview with Nick West, MD, chief medical officer of Shockwave Medical, part of Johnson & Johnson MedTech. They talk about the future calcium modification, intravascular lithotripsy, and the evolving treatment of vascular disease. We’ll start things off with Host Tom Salemi and Chris Newmarker of MassDevice reviewing the newsmakers of the week - BioVentrix, Medical 21, VB Spine, Augmedics, Medtronic, Danaher, and Masimo. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:47) - #5 BioVentrix & Medical 21 IPOs(00:10:24) - #4 VB Spine acquires Augmedics(00:11:35) - #3 Medtronic Stealth Access robotic system(00:13:14) - #2 Medtronic earnings & growth updates(00:17:00) - #1 Danaher to acquire Masimo(00:23:15) - FOMO Interview – Nick West, MD, Chief Medical Officer, Shockwave Medical, part of Johnson & Johnson MedTech(00:23:42) - Part 1 of our interview with Per Bjorkman, Chief Commercial Officer, SHL Healthcare(00:41:31) - Keynote Interview, Jenny Barba, co-founder, Features Capital

    1hr 23min

About

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry. Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges. Our Lineup of Shows Includes: • DeviceTalks Weekly • AbbottTalks • Boston Scientific Talks • DeviceTalks AI • IntuitiveTalks • MedtechWOMEN Talks • MedtronicTalks • Neuro Innovation Talks: J&J MedTech Neurovascular • Structural Heart Talks: Edwards Lifesciences • Ortho Innovation Talks: Enovis & Zimmer Biomet • StrykerTalks Why Subscribe? Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered. If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience. Meet Your Hosts: • Tom Salemi, Editorial Director, DeviceTalks • Kayleen Brown, Managing Editor, DeviceTalks #DeviceTalks, Where Device Makers Connect.

You Might Also Like